{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T16:47:08Z","timestamp":1761842828595},"reference-count":44,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1016\/s1040-8428(01)00124-x","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T01:54:58Z","timestamp":1027648498000},"page":"87-98","source":"Crossref","is-referenced-by-count":22,"title":["Molecular targeting of malignant gliomas with novel multiply-mutated interleukin 13-based cytotoxins"],"prefix":"10.1016","volume":"39","author":[{"given":"Kevin T.","family":"Nash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey P.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldemar","family":"Debinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S1040-8428(01)00124-X_BIB1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/jns.1998.88.1.0001","article-title":"Survival rates in patients with primary brain tumors stratified by patient age and tumor histological type: an analysis based on surveillance, epidemiology, and end results (SEER) data","volume":"88","author":"Davis","year":"1973","journal-title":"J Neurosurg"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/glia.440150303","article-title":"Histopathology, classification, and grading of gliomas","volume":"15","author":"Kleihues","year":"1995","journal-title":"Glia"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB3","series-title":"Neoplasma of the central nervous system. Cancer: principles and practice of oncology","first-page":"1557","author":"Levin","year":"1989"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB4","first-page":"4130","article-title":"Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRIII","volume":"57","author":"Wickstrand","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB5","first-page":"3140","article-title":"Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas","volume":"55","author":"Wikstrand","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB6","first-page":"985","article-title":"Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas","volume":"5","author":"Debinski","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB7","first-page":"481","article-title":"Receptor for interleukin 13 is abundantly and specifically over-expressed in patients with glioblastoma multiforme","volume":"15","author":"Debinski","year":"1999","journal-title":"Int J Oncol"},{"issue":"5","key":"10.1016\/S1040-8428(01)00124-X_BIB8","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/BF03401786","article-title":"Molecular expression analysis of a restrictive receptor for interleukin 13, a brain tumor-associated cancer\/testis antigen","volume":"6","author":"Debinski","year":"2000","journal-title":"Mol Med"},{"issue":"1","key":"10.1016\/S1040-8428(01)00124-X_BIB9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1615\/CritRevOncog.v11.i1.40","article-title":"Cancer genetics\/epigenetics and the X chromosome: Possible new links for malignant glioma pathogenesis and immune-based therapies","volume":"11","author":"Mintz","year":"2000","journal-title":"Crit Rev Oncog"},{"issue":"11","key":"10.1016\/S1040-8428(01)00124-X_BIB10","first-page":"1253","article-title":"Human glioma cells overexpress receptor for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin","volume":"1","author":"Debinski","year":"1995","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB11","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4049\/jimmunol.158.2.756","article-title":"The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor","volume":"158","author":"Obiri","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB12","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1002\/j.1460-2075.1993.tb05927.x","article-title":"Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction","volume":"12","author":"Zurawski","year":"1993","journal-title":"EMBO J"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1073\/pnas.93.1.497","article-title":"Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor","volume":"93","author":"Hilton","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-5793(96)01462-7","article-title":"Cloning of the human IL-13R of a functional IL-4\/IL-13 receptor complex","volume":"40","author":"Miloux","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB15","doi-asserted-by":"crossref","first-page":"29,265","DOI":"10.1074\/jbc.271.46.29265","article-title":"cDNA cloning and characterization of the human interleukin 13 receptor chain","volume":"271","author":"Aman","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1084\/jem.171.3.861","article-title":"Human interleukin-4 receptor confers biological responsiveness and defines a novel receptor superfamily","volume":"171","author":"Idzerda","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB17","doi-asserted-by":"crossref","first-page":"16,921","DOI":"10.1074\/jbc.271.28.16921","article-title":"Cloning and characterization of a specific interleukin (IL13) binding protein structurally related to the IL-5 Receptor chain","volume":"271","author":"Caput","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB18","doi-asserted-by":"crossref","first-page":"22,428","DOI":"10.1074\/jbc.271.37.22428","article-title":"Receptor for IL 13 does not interact with IL4 but receptor for IL4 interacts with IL13 on human glioma cells","volume":"271","author":"Debinski","year":"1996","journal-title":"J Biol Chem"},{"issue":"3&4","key":"10.1016\/S1040-8428(01)00124-X_BIB19","first-page":"255","article-title":"An immune regulatory cytokine receptor and glioblastoma multiforme: an unexpected link","volume":"9","author":"Debinski","year":"1998","journal-title":"Crit Rev Oncogen"},{"issue":"3","key":"10.1016\/S1040-8428(01)00124-X_BIB20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0969-2126(00)00018-6","article-title":"Structural comparisons among the short-chain helical cytokines","volume":"2","author":"Rozwarski","year":"1994","journal-title":"Structure"},{"issue":"9","key":"10.1016\/S1040-8428(01)00124-X_BIB21","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/protein\/7.9.1077","article-title":"Predictive modelling of the 3-D structure of interleukin 13","volume":"7","author":"Bamborough","year":"1994","journal-title":"Protein Engng"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/362248a0","article-title":"Interelukin-13 is a new human lymphokine regulating inflammatory and immune responses","volume":"362","author":"Minty","year":"1993","journal-title":"Nature"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB23","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1073\/pnas.90.8.3735","article-title":"Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function","volume":"90","author":"McKenzie","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/stem.5530120204","article-title":"Interleukin 13 elicits a subset of the activities of its close relative interleukin 4","volume":"12","author":"Zurawski","year":"1994","journal-title":"Stem Cells"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nbt0598-449","article-title":"Novel anti-brain tumor cytotoxins specific for cancer cells","volume":"16","author":"Debinski","year":"1998","journal-title":"Nature Biotech"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB26","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/(SICI)1097-0215(19980518)76:4<547::AID-IJC17>3.0.CO;2-4","article-title":"Novel way to increase targeting specificity to a human glioblastoma-associated receptor for interleukin 13","volume":"76","author":"Debinski","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB27","doi-asserted-by":"crossref","first-page":"29,944","DOI":"10.1074\/jbc.274.42.29944","article-title":"Mutants of interleukin 13 with altered reactivity toward interleukin 13 receptors","volume":"274","author":"Thompson","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB28","first-page":"3143s","article-title":"Retargeting interleukin 13 for radioimmunodetection and radioimmunotherapy of human high grade gliomas","volume":"5","author":"Debinski","year":"1999","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/S1040-8428(01)00124-X_BIB29","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1432-1033.1994.00659.x","article-title":"Design of human interleukin-4 antagonists inhibiting interleukin-4-dependent and interleukin-13-dependent responses in T-cells and B-cells with high efficiency","volume":"225","author":"Tony","year":"1994","journal-title":"Eur J Biochem"},{"issue":"28","key":"10.1016\/S1040-8428(01)00124-X_BIB30","doi-asserted-by":"crossref","first-page":"16,775","DOI":"10.1074\/jbc.270.28.16775","article-title":"A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4","volume":"270","author":"Debinski","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB31","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1073\/pnas.72.6.2284","article-title":"NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin","volume":"72","author":"Iglewski","year":"1975","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB32","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1073\/pnas.83.5.1320","article-title":"Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-\u00c5ngstrom resolution","volume":"83","author":"Allured","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0092-8674(86)90506-4","article-title":"Immunotoxins","volume":"47","author":"Pastan","year":"1986","journal-title":"Cell"},{"issue":"18","key":"10.1016\/S1040-8428(01)00124-X_BIB34","doi-asserted-by":"crossref","first-page":"12,420","DOI":"10.1016\/S0021-9258(18)42291-0","article-title":"The 2-macroglobulin receptor\/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A","volume":"267","author":"Kounnas","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB35","doi-asserted-by":"crossref","first-page":"15,953","DOI":"10.1016\/S0021-9258(18)71572-X","article-title":"Domain II mutants of Pseudomonas exotoxin deficient in translocation","volume":"264","author":"Jinno","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev.bi.61.070192.001555","article-title":"Recombinant toxins as novel therapeutic agents","volume":"61","author":"Pastan","year":"1992","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"10.1016\/S1040-8428(01)00124-X_BIB37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1021\/bc00025a006","article-title":"An immunotoxin with increased activity and homogeneity produced by reducing the number of lysine residues in recombinant Pseudomonas exotoxin","volume":"5","author":"Debinski","year":"1994","journal-title":"Bioconjug Chem"},{"issue":"26","key":"10.1016\/S1040-8428(01)00124-X_BIB38","doi-asserted-by":"crossref","first-page":"13,203","DOI":"10.1016\/S0021-9258(18)37692-0","article-title":"Mutational analysis of domain I of Pseudomonas exotoxin. Mutations in domain I of Pseudomonas exotoxin which reduce cell binding and animal toxicity","volume":"263","author":"Jinno","year":"1988","journal-title":"J Biol Chem"},{"issue":"26","key":"10.1016\/S1040-8428(01)00124-X_BIB39","first-page":"13,203","article-title":"Mutagenesis of Pseudomonas exotoxin in identification of sequences responsible for the animal toxicity","volume":"263","author":"Chaudhary","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0003-2697(92)90280-K","article-title":"Site-directed mutagenesis of virtually any plasmid by eliminating a unique site","volume":"200","author":"Deng","year":"1992","journal-title":"Anal Biochem"},{"issue":"6","key":"10.1016\/S1040-8428(01)00124-X_BIB41","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1182\/blood.V84.6.1913.1913","article-title":"Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukkin-6 production","volume":"84","author":"Sironi","year":"1994","journal-title":"Blood"},{"issue":"10","key":"10.1016\/S1040-8428(01)00124-X_BIB42","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1182\/blood.V87.10.4286.bloodjournal87104286","article-title":"Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain","volume":"87","author":"Schnyder","year":"1996","journal-title":"Blood"},{"issue":"7","key":"10.1016\/S1040-8428(01)00124-X_BIB43","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1073\/pnas.96.7.3957","article-title":"Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome","volume":"96","author":"Baluna","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1040-8428(01)00124-X_BIB44","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/nm1297-1362","article-title":"Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors","volume":"3","author":"Laske","year":"1997","journal-title":"Nature Med"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084280100124X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084280100124X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,16]],"date-time":"2023-04-16T19:01:25Z","timestamp":1681671685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104084280100124X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":44,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["S104084280100124X"],"URL":"https:\/\/doi.org\/10.1016\/s1040-8428(01)00124-x","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}